Key result
Higher cardiac radiation doses linked to increased pericardial disease risk with a median 7-month onset.
Why the study?
Relationships between cardiac substructure radiation dose and specific cardiac events remain poorly understood in cancer patients whose radiation fields overlap the heart.
Do specific cardiac substructure radiation doses associate with distinct adverse cardiac events in patients receiving thoracic radiation therapy?
Do specific cardiac substructure radiation doses associate with distinct adverse cardiac events in patients receiving thoracic radiation therapy?
Specific cardiac substructure radiation doses correlate with distinct adverse cardiac events and onset times, highlighting the need for targeted dose mitigation strategies in cardio-oncology.
May warrant cardiac substructure dose minimization during thoracic RT; hypothesis-generating for tailored cardio-oncology strategies.
Radiation-associated cardiac disease frequently affects cancer patients when radiation fields overlap the heart, but relationships between cardiac substructure dose and specific cardiac events remain poorly understood. This study examined associations between radiation dose to cardiac substructures and adverse cardiac events in thoracic malignancy patients. We retrospectively analyzed 94 patients with lung, esophageal and breast cancers who received radiation therapy. Radiation-induced adverse cardiac events included pericardial disease, atrial fibrillation/flutter, heart failure and valve disease. We evaluated associations between cardiac substructure radiation doses and adverse event types. Results showed that increasing radiation doses to the pericardium, left atrium and whole heart were associated with higher odds of pericardial disease. Median onset times varied: 7 months for pericardial disease, 10 months for atrial fibrillation/flutter and 16 months for heart failure. Clear associations emerged between specific cardiac substructure radiation doses and corresponding adverse event types. Sex-specific differences in cardiac substructure radiation dose were also identified. These findings demonstrate important relationships between cardiac substructure radiation exposure and specific adverse events in patients receiving thoracic radiation therapy. The results underscore the critical importance of considering both cardiac substructure dose distributions and patient sex when developing strategies to mitigate treatment-related cardiac risks in cancer patients.
No takes yet. Share an insight, caveat, or question.
Heller et al. (2025) studied this question. Radiation dose increases to pericardium, left atrium, and whole heart were linked to higher odds of pericardial disease, with median onset at 7 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: